By Dr Dorothy Ann Machalek

Journal articles

Haqshenas G; Molano M; Phillips S; Balgovind P; Garland SM; Hawkes D; Brotherton JML; Machalek DA; Murray G, 2024, 'Evaluation of Seegene Anyplex II Performance for Detection of Human Papillomavirus Genotypes in Formalin-Fixed, Paraffin-Embedded Cervical Cancer Specimens', Archives of Pathology and Laboratory Medicine, 148, pp. 353 - 358, http://dx.doi.org/10.5858/arpa.2022-0317-OA

Haqshenas G; Garland SM; Balgovind P; Cornall A; Danielewski J; Molano M; Machalek DA; Murray G, 2023, 'Development of a touchdown droplet digital PCR assay for the detection and quantitation of human papillomavirus 16 and 18 from self-collected anal samples', Microbiology Spectrum, 11, http://dx.doi.org/10.1128/spectrum.01836-23

Bavor C; Brotherton JM; Smith MA; Prang KH; McDermott T; Rankin NM; Zammit CM; Jennett CJ; Sultana F; Machalek DA; Nightingale CE, 2023, 'The early impacts of primary HPV cervical screening implementation in Australia on the pathology sector: a qualitative study', BMC Health Services Research, 23, http://dx.doi.org/10.1186/s12913-023-10040-6

Lee J; Ismail-Pratt I; Machalek DA; Kumarasamy S; Garland SM, 2023, 'The recovery strategies to support cervical cancer elimination in lower-and middle-income countries (LMICs) following COVID-19 disruptions', Preventive Medicine Reports, 35, http://dx.doi.org/10.1016/j.pmedr.2023.102291

Palmer M; Katanoda K; Saito E; Acuti Martellucci C; Tanaka S; Ikeda S; Sakamoto H; Machalek D; Brotherton JML; Hocking JS, 2023, 'Corrigendum to “Genotype prevalence and age distribution of human papillomavirus from infection to cervical cancer in Japanese women: A systematic review and meta-analysis” [Vaccine 40(41) (2022) 5971–5996, (S0264410X22009501), (10.1016/j.vaccine.2022.07.052)]', Vaccine, 41, pp. 6135, http://dx.doi.org/10.1016/j.vaccine.2023.06.084

Murray GL; Plummer EL; Bodiyabadu K; Vodstrcil LA; Huaman JL; Danielewski JA; Chua TP; Machalek DA; Garland S; Doyle M; Sweeney EL; Whiley DM; Bradshaw CS, 2023, 'gyrA Mutations in Mycoplasma genitalium and Their Contribution to Moxifloxacin Failure: Time for the Next Generation of Resistance-Guided Therapy', Clinical Infectious Diseases, 76, pp. 2187 - 2195, http://dx.doi.org/10.1093/cid/ciad057

Phillips S; Cornall AM; Molano M; Jin F; Roberts JM; Farnsworth A; Hillman RJ; Templeton DJ; Poynten IM; Garland SM; Fairley CK; Murray GL; Tabrizi SN; Grulich AE; Machalek DA, 2023, 'Performance of Human Papillomavirus Attribution Algorithms to Predict Causative Genotypes in Anal High-Grade Lesions', Journal of Infectious Diseases, 227, pp. 1407 - 1416, http://dx.doi.org/10.1093/infdis/jiac503

Brotherton JML; McDermott T; Smith MA; Machalek DA; Shilling H; Prang KH; Jennett C; Nightingale C; Zammit C; Pagotto A; Rankin NM; Kelaher M, 2023, 'Implementation of Australia's primary human papillomavirus (HPV) cervical screening program: The STakeholders Opinions of Renewal Implementation and Experiences Study', Preventive Medicine Reports, 33, http://dx.doi.org/10.1016/j.pmedr.2023.102213

Sharma K; Machalek DA; Toh ZQ; Amenu D; Muchengeti M; Ndlovu AK; Mremi A; Mchome B; Vallely AJ; Denny L; Rees H; Garland SM, 2023, 'No woman left behind: achieving cervical cancer elimination among women living with HIV', The Lancet HIV, 10, pp. e412 - e420, http://dx.doi.org/10.1016/S2352-3018(23)00082-6

Peh CR; Danielewski J; Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Murray GL, 2023, 'Quantitation of Mycoplasma genitalium using droplet digital PCR', Letters in Applied Microbiology, 76, http://dx.doi.org/10.1093/lambio/ovad064

Roberts JM; Machalek DA; Butler BC; Crescini J; Garland SM; Farnsworth A, 2023, 'Older women testing positive for HPV16/18 on cervical screening and risk of high-grade cervical abnormality', International Journal of Cancer, 152, pp. 1593 - 1600, http://dx.doi.org/10.1002/ijc.34393

Bodiybadu K; Danielewski J; Plummer E; Bradshaw CS; Machalek DA; Garland SM; Vodstrcil LA; Murray GL, 2023, 'Comparison of Seegene AnyPlex^TMII STI-7e with standard-of-care diagnostic methods for the detection of Mycoplasma genitalium, Chlamydia trachomatis, Neisseria gonorrhoeae, and Trichomonas vaginalis', Letters in Applied Microbiology, 76, http://dx.doi.org/10.1093/lambio/ovac002

Gandelin M; Tran PL; Chirpaz E; Jaffar-Bandjee MC; Traversier N; Machalek D; Bertolotti A, 2023, 'Human Papillomavirus (HPV) Infections Among Participants Undergoing Chlamydia trachomatis Testing in Reunion Island (RUN-SurV-HPV Study): Protocol for a Prevalence Study', JMIR Research Protocols, 12, http://dx.doi.org/10.2196/47379

Zammit CM; Creagh NS; McDermott T; Smith MA; Machalek DA; Jennett CJ; Prang KH; Sultana F; Nightingale CE; Rankin NM; Kelaher M; Brotherton JML, 2022, '“So, if she wasn’t aware of it, then how would everybody else out there be aware of it?”—Key Stakeholder Perspectives on the Initial Implementation of Self-Collection in Australia’s Cervical Screening Program: A Qualitative Study', International Journal of Environmental Research and Public Health, 19, http://dx.doi.org/10.3390/ijerph192315776

Poynten IM; Jin F; Molano M; Machalek DA; Roberts JM; Hillman RJ; Cornall A; Phillips S; Templeton DJ; Law C; Fairley CK; Grulich AE; Garland SM, 2022, 'Comparison of four assays for human papillomavirus detection in the anal canal', Clinical Microbiology and Infection, 28, pp. 1652.e1 - 1652.e6, http://dx.doi.org/10.1016/j.cmi.2022.06.027

Phillips S; Cassells K; Garland SM; Machalek DA; Roberts JM; Templeton DJ; Jin F; Poynten IM; Hillman RJ; Grulich AE; Murray GL; Tabrizi SN; Molano M; Cornall AM, 2022, 'Gene methylation of CADM1 and MAL identified as a biomarker of high grade anal intraepithelial neoplasia', Scientific Reports, 12, http://dx.doi.org/10.1038/s41598-022-07258-5

Catlett B; Starr M; Machalek DA; Danwilai T; Palmer M; Kelly A; Kaldor J; Dore GJ; Darley D; Matthews G; Cunningham PH, 2022, 'Evaluation of serological assays for SARS-CoV-2 antibody testing from dried blood spots collected from cohorts with prior SARS-CoV-2 infection: SARS-CoV-2 detection from dried blood spots', Journal of Clinical Virology Plus, 2, http://dx.doi.org/10.1016/j.jcvp.2022.100093

Machalek DA; Vette KM; Downes M; Carlin JB; Nicholson S; Hirani R; Irving DO; Gosbell IB; Gidding HF; Shilling H; Aung E; Macartney K; Kaldor JM, 2022, 'Serological testing of blood donors to characterise the impact of COVID-19 in Melbourne, Australia, 2020', PLoS ONE, 17, http://dx.doi.org/10.1371/journal.pone.0265858

Chua TP; Danielewski J; Bodiyabadu K; Bradshaw CS; Machalek DA; Garland SM; Plummer EL; Vodstrcil LA; Murray GL, 2022, 'Impact of 16S rRNA Single Nucleotide Polymorphisms on Mycoplasma genitalium Organism Load with Doxycycline Treatment', Antimicrobial Agents and Chemotherapy, 66, http://dx.doi.org/10.1128/aac.00243-22

Murray GL; Bodiyabadu K; Vodstrcil LA; Machalek DA; Danielewski J; Plummer EL; Garland SM; Whiley DM; Sweeney EL; Bradshaw CS, 2022, 'parC Variants in Mycoplasma genitalium: Trends over Time and Association with Moxifloxacin Failure', Antimicrobial Agents and Chemotherapy, 66, http://dx.doi.org/10.1128/aac.00278-22

Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; Machalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2022, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men (vol 72, pg 853, 2021)', CLINICAL INFECTIOUS DISEASES, 74, http://dx.doi.org/10.1093/cid/ciac150

Shilling HS; Garland SM; Costa AM; Marceglia A; Fethers K; Danielewski J; Murray G; Bradshaw C; Vodstrcil L; Hocking JS; Kaldor J; Guy R; MacHalek DA, 2022, 'Chlamydia trachomatis and Mycoplasma genitalium prevalence and associated factors among women presenting to a pregnancy termination and contraception clinic, 2009-2019', Sexually Transmitted Infections, 98, pp. 115 - 120, http://dx.doi.org/10.1136/sextrans-2020-054695

Vette KM; Machalek DA; Gidding HF; Nicholson S; O'Sullivan MVN; Carlin JB; Downes M; Armstrong L; Beard FH; Dwyer DE; Gibb R; Gosbell IB; Hendry AJ; Higgins G; Hirani R; Hueston L; Irving DO; Quinn HE; Shilling H; Smith D; Kaldor JM; Macartney K, 2022, 'Seroprevalence of Severe Acute Respiratory Syndrome Coronavirus 2-Specific Antibodies in Australia after the First Epidemic Wave in 2020: A National Survey', Open Forum Infectious Diseases, 9, http://dx.doi.org/10.1093/ofid/ofac002

MacHalek D; Rees H; Chikandiwa A; Munthali R; Travill D; Mbulawa Z; Petoumenos K; Delany-Moretlwe S; Kaldor J, 2022, 'Impact of one and two human papillomavirus (HPV) vaccine doses on community-level HPV prevalence in South African adolescent girls: Study protocol and rationale for a pragmatic before-after design', BMJ Open, 12, http://dx.doi.org/10.1136/bmjopen-2021-059968

Chow EPF; Carter A; Vickers T; Fairley CK; McNulty A; Guy RJ; Regan DG; Grulich AE; Callander D; Khawar L; Machalek DA; Donovan B, 2021, 'Effect on genital warts in Australian female and heterosexual male individuals after introduction of the national human papillomavirus gender-neutral vaccination programme: an analysis of national sentinel surveillance data from 2004–18', The Lancet Infectious Diseases, 21, pp. 1747 - 1756, http://dx.doi.org/10.1016/S1473-3099(21)00071-2

Atchison S; Shilling H; Balgovind P; Machalek DA; Hawkes D; Garland SM; Saville M; Murray G; Molano M; Danielewski J; Phillips S, 2021, 'Evaluation of the Roche MagNA Pure 96 nucleic acid extraction platform for the Seegene Anyplex II HPV28 detection assay', Journal of Applied Microbiology, 131, pp. 2592 - 2599, http://dx.doi.org/10.1111/jam.15126

Khawar L; McManus H; Vickers T; Chow EPF; Fairley CK; Donovan B; Machalek DA; Regan DG; Grulich AE; Guy RJ; McGregor S, 2021, 'Genital warts trends in Australian and overseas-born people in Australia: A cross-sectional trend analysis to measure progress towards control and elimination', The Lancet Regional Health - Western Pacific, 16, pp. 100251, http://dx.doi.org/10.1016/j.lanwpc.2021.100251

Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Garland SM; Cornall AM; Atchison S; Hocking JS; Bradshaw CS; Balgovind P; Murray GL; Chen MY, 2021, 'Prevalence of human papillomavirus in young men who have sex with men after the implementation of gender-neutral HPV vaccination: a repeated cross-sectional study', The Lancet Infectious Diseases, 21, pp. 1448 - 1457, http://dx.doi.org/10.1016/S1473-3099(20)30687-3

Shilling H; Garland SM; Atchison S; Cornall AM; Brotherton JML; Bateson D; McNamee K; Kaldor JM; Hocking JS; Chen MY; Fairley CK; McNulty A; Bell C; Marshall L; Ooi C; Skinner SR; Murray G; Molano M; Tabrizi S; Machalek DA, 2021, 'Human papillomavirus prevalence and risk factors among Australian women 9–12 years after vaccine program introduction', Vaccine, 39, pp. 4856 - 4863, http://dx.doi.org/10.1016/j.vaccine.2021.07.005

Gidding HF; Machalek DA; Hendry AJ; Quinn HE; Vette K; Beard FH; Shilling HS; Hirani R; Gosbell IB; Irving DO; Hueston L; Downes M; Carlin JB; O'Sullivan MVN; Dwyer DE; Kaldor JM; Macartney K, 2021, 'Seroprevalence of SARS-CoV-2-specific antibodies in Sydney after the first epidemic wave of 2020', Medical Journal of Australia, 214, pp. 179 - 185, http://dx.doi.org/10.5694/mja2.50940

Brotherton JML; Wheeler C; Clifford GM; Elfström M; Saville M; Kaldor J; Machalek DA, 2021, 'Surveillance systems for monitoring cervical cancer elimination efforts: Focus on HPV infection, cervical dysplasia, cervical screening and treatment', Preventive Medicine, 144, http://dx.doi.org/10.1016/j.ypmed.2020.106293

Poynten IM; Jin F; Roberts JM; Templeton DJ; Law C; Cornall AM; Molano M; MacHalek DA; Carr A; Farnsworth A; Tabrizi S; Phillips S; Fairley CK; Garland SM; Hillman RJ; Grulich AE, 2021, 'The Natural History of Anal High-grade Squamous Intraepithelial Lesions in Gay and Bisexual Men', Clinical Infectious Diseases, 72, pp. 853 - 861, http://dx.doi.org/10.1093/cid/ciaa166

Bodiyabadu K; Danielewski J; Garland SM; Machalek DA; Bradshaw CS; Birnie J; Ebeyan S; Lundgren M; Murray G, 2021, 'Detection of parC gene mutations associated with quinolone resistance in Mycoplasma genitalium: Evaluation of a multiplex real-time PCR assay', Journal of Medical Microbiology, 70, http://dx.doi.org/10.1099/jmm.0.001257

Chua TP; Bodiyabadu K; Machalek DA; Garland SM; Bradshaw CS; Plummer EL; Danielewski J; Vodstrcil LA; Doyle ML; Murray GL, 2021, 'Prevalence of Mycoplasma genitalium fluoroquinolone-resistance markers, and dual-class-resistance markers, in asymptomatic men who have sex with men', Journal of Medical Microbiology, 70, http://dx.doi.org/10.1099/jmm.0.001429

Farnsworth A; Roberts JM; Garland SM; Crescini J; Kaldor JM; Machalek DA, 2020, 'Detection of high-grade cervical disease among women referred directly to colposcopy after a positive HPV screening test varies with age and cytology findings', International Journal of Cancer, 147, pp. 3068 - 3074, http://dx.doi.org/10.1002/ijc.33128

Latimer RL; Shilling HS; Vodstrcil LA; MacHalek DA; Fairley CK; Chow EPF; Read TRH; Bradshaw CS, 2020, 'Prevalence of Mycoplasma genitalium by anatomical site in men who have sex with men: A systematic review and meta-analysis', Sexually Transmitted Infections, 96, pp. 563 - 570, http://dx.doi.org/10.1136/sextrans-2019-054310

Machalek DA; Tao Y; Shilling H; Jensen JS; Unemo M; Murray G; Chow EPF; Low N; Garland SM; Vodstrcil LA; Fairley CK; Hocking JS; Zhang L; Bradshaw CS, 2020, 'Prevalence of mutations associated with resistance to macrolides and fluoroquinolones in Mycoplasma genitalium: a systematic review and meta-analysis', The Lancet Infectious Diseases, 20, pp. 1302 - 1314, http://dx.doi.org/10.1016/S1473-3099(20)30154-7

Roberts JM; Poynten IM; Molano M; Machalek DA; Hillman RJ; Guzman P; Jin F; Templeton DJ; Fairley CK; Law C; Garland SM; Grulich AE; Cornall AM; Cunningham P, 2020, 'Human papillomavirus genotypes in anal high-grade squamous intraepithelial lesion (HSIL): Anal intraepithelial neoplasia grades 2 (AIN2) and 3 (AIN3) are different', Cancer Epidemiology Biomarkers and Prevention, 29, pp. 2078 - 2083, http://dx.doi.org/10.1158/1055-9965.EPI-20-0664

Khawar L; Machalek DA; Regan DG; Donovan B; McGregor S; Guy RJ, 2020, 'Defining elimination of genital warts—a modified delphi study', Vaccines, 8, pp. 1 - 17, http://dx.doi.org/10.3390/vaccines8020316

Murray GL; Bodiyabadu K; Danielewski J; Garland SM; MacHalek DA; Fairley CK; Jensen JS; Williamson DA; Tan LY; Mokany E; Durukan D; Bradshaw CS, 2020, 'Moxifloxacin and Sitafloxacin Treatment Failure in Mycoplasma genitalium Infection: Association with parC Mutation G248T (S83I) and Concurrent gyrA Mutations', Journal of Infectious Diseases, 221, pp. 1017 - 1024, http://dx.doi.org/10.1093/infdis/jiz550

Shilling H; Murray G; Brotherton JML; Hawkes D; Saville M; Sivertsen T; Chambers I; Roberts J; Farnsworth A; Garland SM; Hocking JS; Kaldor J; Guy R; Atchison S; Costa AM; Molano M; Machalek DA, 2020, 'Monitoring human papillomavirus prevalence among young Australian women undergoing routine chlamydia screening', Vaccine, 38, pp. 1186 - 1193, http://dx.doi.org/10.1016/j.vaccine.2019.11.019

Murray GL; Doyle M; Bodiyabadu K; Vodstrcil LA; Garland SM; Danielewski J; Machalek DA; McGuinness C; Plummer EL; de Petra V; Williamson DA; Bradshaw CS, 2020, 'Evaluation of ResistancePlus MG FleXible, a 'near-patient' test for the detection of Mycoplasma genitalium and macrolide resistance mutations, using freshly collected clinical samples', Journal of Medical Microbiology, 70, http://dx.doi.org/10.1099/JMM.0.001271

Murray GL; Danielewski J; Bradshaw CS; Williamson DA; Birnie J; Su JP; De Petra V; Tan LY; Wee R; MacHalek DA; Read TRH; Garland SM, 2020, 'Performance of the ResistancePlus MG diagnostic test for Mycoplasma genitalium using samples collected with Hologic Aptima Specimen Collection kits', Journal of Medical Microbiology, 69, pp. 244 - 248, http://dx.doi.org/10.1099/jmm.0.001140

Chow EPF; Tabrizi SN; Fairley CK; Wigan R; Machalek DA; Regan DG; Hocking JS; Garland SM; Cornall AM; Atchison S; Bradshaw CS; McNulty A; Owen L; Marshall L; Russell DB; Kaldor JM; Chen MY, 2019, 'Prevalence of human papillomavirus in teenage heterosexual males following the implementation of female and male school-based vaccination in Australia: 2014–2017', Vaccine, 37, pp. 6907 - 6914, http://dx.doi.org/10.1016/j.vaccine.2019.09.052

Murray GL; Su JP; Birnie J; Danielewski J; Machalek DA; Bradshaw CS; Read TRH; Costa AM; Garland SM, 2019, 'The impact of sample storage on molecular-based detection of Mycoplasma genitalium', Journal of Applied Microbiology, 127, pp. 1219 - 1223, http://dx.doi.org/10.1111/jam.14359

Drolet M; Bénard É; Pérez N; Brisson M; Ali H; Boily MC; Baldo V; Brassard P; Brotherton JML; Callander D; Checchi M; Chow EPF; Cocchio S; Dalianis T; Deeks SL; Dehlendorff C; Donovan B; Fairley CK; Flagg EW; Gargano JW; Garland SM; Grün N; Hansen BT; Harrison C; Herweijer E; Imburgia TM; Johnson AM; Kahn JA; Kavanagh K; Kjaer SK; Kliewer EV; Liu B; Machalek DA; Markowitz L; Mesher D; Munk C; Niccolai L; Nygård M; Ogilvie G; Oliphant J; Pollock KG; Purriños-Hermida MJ; Smith MA; Steben M; Söderlund-Strand A; Sonnenberg P; Sparen P; Tanton C; Wheeler CM; Woestenberg PJ; Yu BN, 2019, 'Population-level impact and herd effects following the introduction of human papillomavirus vaccination programmes: updated systematic review and meta-analysis', The Lancet, 394, pp. 497 - 509, http://dx.doi.org/10.1016/S0140-6736(19)30298-3

Brotherton JM; Hawkes D; Sultana F; Malloy MJ; Machalek DA; Smith MA; Garland SM; Saville M, 2019, 'Age-specific HPV prevalence among 116,052 women in Australia's renewed cervical screening program: A new tool for monitoring vaccine impact', Vaccine, 37, pp. 412 - 416, http://dx.doi.org/10.1016/j.vaccine.2018.11.075

Murray GL; Danielewski J; Bodiyabadu K; Machalek DA; Bradshaw CS; Costa AM; Birnie J; Garland SM, 2019, 'Analysis of infection loads in Mycoplasma genitalium clinical specimens by use of a commercial diagnostic test', Journal of Clinical Microbiology, 57, http://dx.doi.org/10.1128/JCM.00344-19

Machalek DA; Roberts JM; Garland SM; Thurloe J; Richards A; Chambers I; Sivertsen T; Farnsworth A, 2019, 'Routine cervical screening by primary HPV testing: early findings in the renewed National Cervical Screening Program', Medical Journal of Australia, 211, pp. 113 - 119, http://dx.doi.org/10.5694/mja2.50223

Elder K; Nickson C; Pattanasri M; Cooke S; Machalek D; Rose A; Mou A; Collins JP; Park A; De Boer R; Phillips C; Pridmore V; Farrugia H; Bruce Mann G, 2018, 'Treatment Intensity Differences After Early-Stage Breast Cancer (ESBC) Diagnosis Depending on Participation in a Screening Program', Annals of Surgical Oncology, 25, pp. 2563 - 2572, http://dx.doi.org/10.1245/s10434-018-6469-7

Back to profile page